| P50 | author | Hyun Jung Kim | Q51541196 |
| P2093 | author name string | Woojung Shin | |
| P2860 | cites work | Role of 5-aminosalicylic acid (5-ASA) in treatment of inflammatory bowel disease: a systematic review. | Q34575542 |
| | Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG. | Q35594940 |
| | Experimental Models of Inflammatory Bowel Diseases | Q35618798 |
| | Inflammatory networks underlying colorectal cancer | Q35925068 |
| | Granulocyte macrophage colony-stimulating factor ameliorates DSS-induced experimental colitis | Q36045739 |
| | Elevated lipopolysaccharide in the colon evokes intestinal inflammation, aggravated in immune modulator-impaired mice | Q36176048 |
| | Lipopolysaccharide Regulation of Intestinal Tight Junction Permeability Is Mediated by TLR4 Signal Transduction Pathway Activation of FAK and MyD88. | Q36260383 |
| | Immune cell migration in inflammation: present and future therapeutic targets | Q36348737 |
| | CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells | Q36361889 |
| | Suppression of dextran sulfate sodium-induced colitis in mice by radon inhalation | Q36520274 |
| | A microfluidics-based in vitro model of the gastrointestinal human-microbe interface | Q36898152 |
| | Safety of probiotics: translocation and infection | Q37119139 |
| | Role of probiotic therapy in IBD. | Q37141846 |
| | NF-kappaB in inflammatory bowel disease | Q37163422 |
| | Intestinal barrier dysfunction in inflammatory bowel diseases. | Q37214839 |
| | Lessons from probiotic-host interaction studies in murine models of experimental colitis | Q37907198 |
| | Anti-TNF monoclonal antibodies in inflammatory bowel disease: pharmacokinetics-based dosing paradigms | Q37987352 |
| | Redox activation of Nrf2 & NF-κB: a double end sword? | Q38133119 |
| | Gastrointestinal motility disorders in inflammatory bowel diseases | Q38177780 |
| | Emulating Host-Microbiome Ecosystem of Human Gastrointestinal Tract in Vitro. | Q38685792 |
| | VSL#3 probiotics regulate the intestinal epithelial barrier in vivo and in vitro via the p38 and ERK signaling pathways | Q39442024 |
| | Signaling pathway via TNF-alpha/NF-kappaB in intestinal epithelial cells may be directly involved in colitis-associated carcinogenesis | Q39889562 |
| | Cell culture model for colon cancer prevention and therapy: an alternative approach to animal experimentation. | Q40158803 |
| | Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation. | Q40456395 |
| | Probiotic bacteria enhance murine and human intestinal epithelial barrier function | Q40783633 |
| | Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer | Q42152237 |
| | Gut-on-a-Chip microenvironment induces human intestinal cells to undergo villus differentiation | Q42440768 |
| | Wound healing of intestinal epithelial cells | Q42732189 |
| | Visible small-intestinal mucosal injury in chronic NSAID users | Q45220712 |
| | Co-culture of Living Microbiome with Microengineered Human Intestinal Villi in a Gut-on-a-Chip Microfluidic Device | Q46484183 |
| | SGLT-1-mediated glucose uptake protects intestinal epithelial cells against LPS-induced apoptosis and barrier defects: a novel cellular rescue mechanism? | Q46783993 |
| | Microfluidic gut-on-a-chip with three-dimensional villi structure | Q48220816 |
| | Modeling radiation injury-induced cell death and countermeasure drug responses in a human Gut-on-a-Chip. | Q51419671 |
| | Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow. | Q51541144 |
| | Bioengineered Systems and Designer Matrices That Recapitulate the Intestinal Stem Cell Niche. | Q52314668 |
| | Lactobacillus casei subsp. rhamnosus sepsis in a patient with ulcerative colitis. | Q52543646 |
| | Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis. | Q54142966 |
| | Microfluidic Organ-on-a-Chip Models of Human Intestine. | Q55035407 |
| | Impaired On/Off Regulation of TNF Biosynthesis in Mice Lacking TNF AU-Rich Elements | Q62819809 |
| | Hapten-induced model of chronic inflammation and ulceration in the rat colon | Q69942171 |
| | Spontaneous, heritable colitis in a new substrain of C3H/HeJ mice | Q72800593 |
| | Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome | Q79927899 |
| | Animal models of inflammatory bowel disease | Q80600314 |
| | Probiotic effects of Lactobacillus casei on DSS-induced ulcerative colitis in mice | Q81014180 |
| | Role of Nrf2 in oxidative stress and toxicity | Q23919669 |
| | Lipopolysaccharide endotoxins | Q24650970 |
| | Does the Interdependence between Oxidative Stress and Inflammation Explain the Antioxidant Paradox? | Q26765800 |
| | Dextran sodium sulphate colitis mouse model: traps and tricks | Q27001084 |
| | Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip | Q27316911 |
| | Detection of colorectal dysplasia using fluorescently labelled lectins. | Q27322613 |
| | Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut | Q28081848 |
| | Probiotic use in clinical practice: what are the risks? | Q28245049 |
| | Reactive oxygen production induced by the gut microbiota: pharmacotherapeutic implications | Q28384349 |
| | Reactive oxygen species in inflammation and tissue injury | Q28396273 |
| | Interleukin-10-deficient mice develop chronic enterocolitis | Q29547881 |
| | Intestinal homeostasis and its breakdown in inflammatory bowel disease | Q29620336 |
| | Emergence of perianal fistulizing disease in the SAMP1/YitFc mouse, a spontaneous model of chronic ileitis | Q30310728 |
| | Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases | Q33427772 |
| | Temporal and spatial analysis of clinical and molecular parameters in dextran sodium sulfate induced colitis | Q33475620 |
| | Review article: the role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases | Q33785337 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 45 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microbiome | Q1330402 |
| P304 | page(s) | E10539-E10547 | |
| P577 | publication date | 2018-10-22 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Intestinal barrier dysfunction orchestrates the onset of inflammatory host-microbiome cross-talk in a human gut inflammation-on-a-chip | |
| P478 | volume | 115 | |